Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfPEBS-LSP malaria vaccine phase I/IIa challenge study
NL-OMON37083Phase 1Withdrawn
- Sponsor
- Vac4All
- Start
- Jun 2012
- Modality
- Vaccines & Immunotherapeutics, Peptides
- Countries
- 1
01
Overview
Phase 1, open-label trial of PfPEBS-LSP in malaria and Falciparum malaria (PF) (3 arms), sponsored by Vac4All. Primary endpoints: Safety in phase I and Protective efficacy against liver stages in phase IIa. Planned start Jun 2012; status: withdrawn.
02
Drugs
PfPEBS-LSP
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on NL-OMON37083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37083.